| 11:30–11:40 | Marina Mosunjac, Emory University: Cervical Pap Smears in Transgender Male Population at an Inner-city Hospital; A Retrospective Study |
| 11:40–11:50 | Ayesha Baig, University of Calgary Dynalife Medical Labs and Alberta Precision Laboratories. Calgary, AB, Canada: An evaluation of cervicovaginal Papanicolaou tests from transgender patients on testosterone therapy in a tertiary care center in Canada – remote presentation |
| 11:50–12:00 | Barbara Sepodes, Centro Hospitalar e Universitario de Coimbra: Optimization of HPV positive women triage with p16/ki67 double staining in an organized screening program |
| 12:00–12:10 | Pablo Santiago Díaz, Hospital del Mar, Barcelona (Spain): Results from HPV-based opportunistic cervical cancer screening in Barcelona, Spain |
| 12:10–12:20 | Rosario Granados, Hospital Universitario De Getafe: Predictive Value of Atypical Glandular Cells in Liquid-Based Cytology for Uterine Adenocarcinoma. Differences Diagnosing Endocervical and Endometrial Tumors |
| 12:20–12:30 | Maurizio Pinamonti, Azienda Sanitaria-Universitaria Giuliano-Isontina – Hospital of Cattinara: Evaluation of Self-sampling-based Cervical Cancer Screening Strategy using HPV Selfy CE IVD Test coupled with Home-Collection Kit: a Clinical Study in Italy |
| 12:30–12:40 | Zsuzsanna Bánrévi, Selbständiges Ambulatorium Zytologisches Institut, Graz: „Lookalikes” in cervical smears |
